Automated Immunoassay Analyzers Market Report 2024

The automated immunoassay analyzer market size has grown rapidly in recent years. It will grow from $17.69 billion in 2023 to $20.2 billion in 2024 at a compound annual growth rate (CAGR) of 14.5%. The growth during the historic period can be attributed to several factors are the rising demand for accurate and rapid diagnostic tests, the increasing prevalence of chronic diseases such as diabetes and cancer that require frequent monitoring, advancements in immunoassay technologies enhancing testing efficiency and precision, the expansion of healthcare infrastructure in emerging economies improving access to diagnostic tools, and increased investments in research and development by major healthcare companies aimed at innovating and refining diagnostic solutions.

The automated immunoassay analyzer market size is expected to see rapid growth in the next few years. It will grow to $34.92 billion in 2028 at a compound annual growth rate (CAGR) of 14.6%. The anticipated growth during the forecast period can be attributed to several key factors, advancements in automation technologies that enhance the efficiency and accuracy of analyzers, the rising prevalence of infectious diseases, an increasing focus on personalized medicine that demands more sophisticated immunoassay solutions, expanding global healthcare expenditures that improve the affordability and accessibility of advanced diagnostic tools, and the integration of digital health solutions which enhance analyzer functionality and data management. Major trends expected include the increased adoption of multiplex immunoassays for simultaneous detection of multiple analytes, growth in point-of-care testing (POCT) technologies for on-site and rapid diagnostics, the emergence of AI and machine learning to improve accuracy and predictive analytics in immunoassays, the rising use of advanced bioinformatics tools for data analysis and interpretation, and the growing presence of portable and user-friendly analyzers suited for various healthcare settings and applications.

The growth of the automated immunoassay analyzer market is anticipated to be driven by the increasing number of hospitals. This rise is attributed to the growing healthcare needs of an expanding and aging population. Automated immunoassay analyzers improve efficiency and accuracy in hospitals by quickly processing large volumes of diagnostic tests for a range of diseases and conditions. For example, in May 2023, the American Health Care Association reported an increase in the number of hospitals in the US to 6,129 from 6,093 in 2022, representing a 0.59% growth. This expansion in hospital numbers is fueling the demand for automated immunoassay analyzers.

Leading companies in the automated immunoassay analyzer market are focusing on developing advanced products, such as compact immunoassay analyzers, to gain a competitive edge. These compact devices are designed for conducting immunoassay tests to detect specific biomarkers in biological samples and offer convenience and efficiency in various healthcare settings, especially where space and mobility are constraints. For instance, in July 2023, Siemens Healthineers, a Germany-based healthcare company, introduced the Atellica CI Analyzer. This compact system combines immunoassay and clinical chemistry testing into a single platform, addressing the growing demand for versatile and efficient testing solutions. The Atellica CI Analyzer features random access sampling, micro-volume aspiration, and automated maintenance and quality control scheduling to enhance the consistency and predictability of sample processing times.

In October 2022, DiaSorin S.p.A., an Italy-based biotechnology company, acquired Luminex Corporation for $1.8 billion. This acquisition is intended to bolster DiaSorin's diagnostics and life sciences capabilities by integrating Luminex's multiplexing assay technology, thereby expanding its product offerings and strengthening its position in the global molecular diagnostics and immunoassay markets. Luminex Corporation, based in the US, specializes in automated immunoassay analyzers.

Major companies operating in the automated immunoassay analyzers market are Roche Diagnostics AG, Abbott Laboratories, Danaher Corporation, Siemens Healthineers, Becton Dickinson and Company, Medline Industries LP, Tosoh Corporation, Agilent Technologies Inc, bioMérieux SA, QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc, Qiagen NV, Werfen Group SA, DiaSorin SpA, Bio-Techne Corporation, Meril Life Sciences Private Limited, Randox Laboratories Ltd, Getein Biotech Inc, Aesku Diagnostics GmbH & Co KG, Carolina Liquid Chemistries Corporation, Arlington Scientific Inc, Chengdu Seamaty Technology Co Ltd, Hipro Biotechnology Co Ltd.

North America was the largest region in the automated immunoassay analyzer market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated immunoassay analyzers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the automated immunoassay analyzers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Automated immunoassay analyzers are sophisticated laboratory instruments designed to conduct immunoassays with minimal human input. These analyzers automate the detection and measurement of specific proteins, hormones, and other substances in biological samples, enhancing accuracy and efficiency in diagnostic testing. They are commonly used in clinical laboratories for disease diagnosis, monitoring, and research purposes.

The primary types of automated immunoassay analyzers include immunofluorescence, chemiluminescence, enzyme-linked immunosorbent assay (ELISA), multiplexed assay systems, and radioimmunoassay. Immunofluorescence is a technique that employs fluorescent-labeled antibodies to identify specific antigens in biological samples. These analyzers are applied in various fields, including infectious diseases, endocrinology, drug monitoring, cardiology, oncology, and allergy testing. They are utilized by hospitals, diagnostic laboratories, research and academic institutions, as well as pharmaceutical and biotechnology companies.

The automated immunoassay analyzers market research report is one of a series of new reports that provides automated immunoassay analyzers market statistics, including automated immunoassay analyzers industry global market size, regional shares, competitors with an automated immunoassay analyzers market share, detailed automated immunoassay analyzers market segments, market trends, and opportunities, and any further data you may need to thrive in the automated immunoassay analyzers industry. This automated immunoassay analyzers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The automated immunoassay analyzers market consists of sales of sample handlers, reagents, incubation chambers, thermal printers, and wash stations. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.